Efficacy of high-dose intra-dermal hepatitis B virus vaccine in previous vaccination non-responders with chronic liver disease

Digestive Diseases and Sciences

Volumn 57, Issue 1, 2012, Pages 215-220

  Dhillon, S ^a   Moore, C ^b   Li, S D ^e   Aziz, A ^e   Kakar, A ^d   Dosanjh, A ^d   Beesla, A ^d   Murphy, L ^c   Van Thiel, D H ^b  

^a OSF SAINT FRANCIS MEDICAL CENTER   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^d Premier Medical Associates   (United States)

^e NONE

Author keywords

Chronic liver disease; HBV immunity; Hepatitis B virus; Intra dermal vaccination

Indexed keywords

HEPATITIS B CORE ANTIBODY; RECOMBINANT HEPATITIS B VACCINE;

ADULT; ANTIBODY TITER; ARTICLE; CHRONIC KIDNEY DISEASE; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; DIABETES MELLITUS; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; DRUG SAFETY; EPIDEMIOLOGY; ERYTHEMA; FEMALE; HUMAN; IMMUNE RESPONSE; INJECTION SITE REACTION; KELOID; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL; SEROLOGY; SKIN INFLAMMATION; STANDARD; SWELLING; TREATMENT FAILURE; VACCINATION;

ADULT; AGED; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; INJECTIONS, INTRADERMAL; LIVER DISEASES; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84856757537     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-011-1996-0     Document Type: Article

References (30)

1. CW Shepard EP Simard L Finelli AE Fiore BP Bell 2006 Hepatitis B virus infection: epidemiology and vaccination Epidemiol Rev 28 112 125 16754644 10.1093/epirev/mxj009 (Pubitemid 44289094)
2. World Health Organization. Hepatitis B. (Fact sheet no. 204). Geneva, Switzerland: World Health Organization, 2000. http://www.who.int/mediacentre/ factsheets/fs204/en/.
3. AR Zanetti P Van Damme D Shouval Vaccine 2008 The global impact of vaccination against hepatitis B: a historical overview Vaccine 26 6266 6273 18848855 10.1016/j.vaccine.2008.09.056
4. M Wiedmann UG Liebert U Oesen H Porst M Wiese S Schroeder U Halm J Mössner F Berr 2000 Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C Hepatology 31 230 234 10613751 10.1002/hep.510310134 1:STN:280:DC%2BD3c%2FotVyktg%3D%3D (Pubitemid 30033712)
5. A Aziz S Aziz DS Li L Murphy N Leone M Kennedy S Dhillon DH Van Thiel 2006 Efficacy of repeated high-dose hepatitis B vaccine (80 μg) in patients with chronic liver disease J Viral Hepat 13 217 221 16611186 10.1111/j.1365-2893.2005.00674.x 1:STN:280:DC%2BD283gsFOrtQ%3D%3D
6. EB Keeffe 2005 Acute hepatitis A and B in patients with chronic liver disease: prevention through vaccination Am J Med 118 21S 27S 16271537 10.1016/j.amjmed.2005.07.013 (Pubitemid 41552428)
7. L Sangaré L Manhart D Zehrung CC Wang 2009 Intradermal hepatitis B vaccination: a systematic review and meta-analysis Vaccine 27 1777 1786 19200451 10.1016/j.vaccine.2009.01.043
8. B Kallinowski C Benz L Buchholz W Stremmel 1998 Accelerated schedule of hepatitis B vaccination in liver transplant candidates Transplant Proc 30 797 799 9595103 10.1016/S0041-1345(98)00053-0 1:STN:280:DyaK1c3lslCmuw%3D%3D (Pubitemid 28216809)
9. AS Rosman P Basu K Galvin CS Lieber 1997 Efficacy of a high and accelerated dose of hepatitis B vaccine in alcoholic patients: a randomized clinical trial Am J Med 103 217 222 9316554 10.1016/S0002-9343(97)00132-0 1:STN:280:DyaK2svmt1artg%3D%3D (Pubitemid 27413404)
10. F Fabrizi V Dixit P Messa P Martin 2010 Intradermal vs intramuscular vaccine against hepatitis B infection in dialysis patients: a meta-analysis of randomized trials J Viral Hepat 31 1 8
11. EA Arbizu RB Marugán JY Grijalba PL Serrano LG Grande S Del Campo Terrón 2003 Intramuscular versus intradermal administration of anti-hepatitis B vaccine in non-cirrhotic hepatitis C patients Vaccine 21 2747 2750 12798613 10.1016/S0264-410X(03)00221-4 1:CAS:528:DC%2BD3sXksVyru74%3D (Pubitemid 36703186)
12. ST Goldstein F Zhou SC Hadler BP Bell EE Mast HS Margolis 2005 A mathematical model to estimate global hepatitis B disease burden and vaccination impact Int J Epidemiol 34 1329 1339 16249217 10.1093/ije/dyi206 (Pubitemid 41819540)
13. MR Arguedas BM McGuire MB Fallon 2002 Implementation of vaccination in patients with cirrhosis Dig Dis Sci 47 384 387 11855555 10.1023/A:1013734525348 (Pubitemid 34123999)
14. GA Poland 2005 Evaluating existing recommendations for hepatitis A and B vaccination Am J Med 118 16S 20S 16271536 10.1016/j.amjmed.2005.07.029 (Pubitemid 41552427)
15. JR Kramer CY Hachem F Kanwal M Mei HB El-Serag 2011 Meeting vaccination quality measures for hepatitis A and B virus in patients with chronic hepatitis C infection Hepatology 53 42 52 21254161 10.1002/hep.24024
16. MA Wörns A Teufel S Kanzler A Shrestha A Victor G Otto AW Lohse PR Galle T Höhler 2008 Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases Am J Gastroenterol 103 138 146 17970833 10.1111/j.1572-0241.2007.01609.x
17. SH Engler PW Sauer M Golling EA Klar C Benz W Stremmel B Kallinowski 2001 Immunogenicity of two accelerated hepatitis B vaccination protocols in liver transplant candidates Eur J Gastroenterol Hepatol 13 363 367 11338063 10.1097/00042737-200104000-00010 1:CAS:528:DC%2BD3MXktVartLk%3D (Pubitemid 32319900)
18. L Castells R Esteban 2001 Hepatitis B vaccination in liver transplant candidates Eur J Gastroenterol Hepatol 13 359 361 11338062 10.1097/00042737- 200104000-00009 1:CAS:528:DC%2BD3MXktVartLg%3D (Pubitemid 32319899)
19. T Niiya SM Akbar O Yoshida T Miyake B Matsuura H Murakami M Abe Y Hiasa M Onji 2007 Impaired dendritic cell function resulting from chronic undernutrition disrupts the antigen-specific immune response in mice J Nutr 137 671 675 17311958 1:CAS:528:DC%2BD2sXisVygsLw%3D (Pubitemid 46397501)
20. S Ghebrehewet D Baxter M Falconer K Paver 2008 Intradermal recombinant hepatitis B vaccination (IDRV) for non-responsive healthcare workers (HCWs) Hum Vaccin 4 280 285 18398298 10.4161/hv.4.4.5687 1:CAS:528:DC%2BD1cXhtVeisLvM
21. R Peces M de la Torre R Alcázar JM Urra 1997 Prospective analysis of the factors influencing the antibody response to hepatitis B vaccine in hemodialysis patients Am J Kidney Dis 29 239 245 9016896 10.1016/S0272-6386(97) 90036-6 1:STN:280:DyaK2s7mvFSruw%3D%3D (Pubitemid 27130735)
22. CDC 2001 Recommendations for preventing transmission of infections among chronic hemodialysis patients MMWR 50 1 43
23. RB Belshe FK Newman J Cannon C Duane J Treanor C Van Hoecke BJ Howe G Dubin 2004 Serum antibody responses after intradermal vaccination against influenza N Engl J Med 351 2286 2294 15525713 10.1056/NEJMoa043555 1:CAS:528:DC%2BD2cXhtValtr7I (Pubitemid 39552744)
24. GJ Nossal 1997 Host immunobiology and vaccine development Lancet 350 1316 1319 9357421 10.1016/S0140-6736(97)03257-1 1:STN:280:DyaK1c%2FitVaqsw%3D%3D (Pubitemid 28036649)
25. A Sabchareon P Chantavanich S Pasuralertsakul C Pojjaroen-Anant V Prarinyanupharb P Attanath V Singhasivanon W Buppodom J Lang 1998 Persistence of antibodies in children after intradermal or intramuscular administration of preexposure primary and booster immunizations with purified Vero cell rabies vaccine Pediatr Infect Dis J 17 1001 1007 9849982 10.1097/00006454-199811000- 00007 1:STN:280:DyaK1M%2FmsFagtg%3D%3D (Pubitemid 28549419)
26. S Chutivongse H Wilde C Supich GM Baer DB Fishbein 1990 Postexposure prophylaxis for rabies with antiserum and intradermal vaccination Lancet 335 896 898 1969993 10.1016/0140-6736(90)90488-Q 1:STN:280:DyaK3c3itVSrsw%3D%3D (Pubitemid 20136790)
27. P Phanuphak P Khawplod S Sirivichayakul W Siriprasomsub S Ubol M Thaweepathomwat 1987 Humoral and cell-mediated immune responses to various economical regimens of purified Vero cell rabies vaccine Asian Pac J Allergy Immunol 5 33 37 3620048 1:STN:280:DyaL2s3pvVyjsA%3D%3D
28. P Sangfelt I Uhnoo O Reichard O Weiland 2008 A low-dose intradermal hepatitis B vaccine programme in health-care workers and students is highly effective and cost saving: a retrospective follow-up survey in the clinical setting Scand J Gastroenterol 43 465 472 18365912 10.1080/00365520701733806 (Pubitemid 351450986)
29. AB McDermott SBA Cohen JN Zuckerman JA Madrigal 1999 Human leukocyte antigens influence the immune response to a pre-S/S hepatitis vaccine Vaccine 17 330 339 9987171 10.1016/S0264-410X(98)00203-5 1:CAS:528:DyaK1MXktlGisQ%3D%3D (Pubitemid 28557180)
30. S Caillat-Zucman JJ Gimenez F Wambergue G Albouze B Lebkiri C Naret A Moynot P Jungers JF Bach 1998 Distinct HLA class II alleles determine antibody response to vaccination with hepatitis B surface antigen Kidney Int 53 1626 1630 9607193 10.1046/j.1523-1755.1998.00909.x 1:CAS:528:DyaK1cXjs12lsr4%3D (Pubitemid 28243745)